The Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis With Histological Examination of the Resected Specimen
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Carcinoma, Non Small Cell Lung
Both
Carcinoma, Non Small Cell Lung
Trial Information
The Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis With Histological Examination of the Resected Specimen
Inclusion Criteria:
-Patients with non small cell lung cancer and atelectasis, who are eligible for surgery.
Exclusion Criteria:
- age < 18 years
- pregnancy
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Histological validation of CT-PET image fusion.
Principal Investigator
Jan Bussink, MD, PhD
Investigator Role:
Study Director
Investigator Affiliation:
Radiation oncologist, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Authority:
Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study ID:
2004/032
NCT ID:
NCT00184964
Start Date:
June 2004
Completion Date:
Related Keywords:
- Carcinoma, Non Small Cell Lung
- Pulmonary Atelectasis
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
Name | Location |
|---|
